This document provides requirements and recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens.
This document is applicable to medical laboratories. It is also intended to be used by in vitro diagnostic developers and manufacturers, as well as by institutions and organizations supporting SARS-CoV-2 research and diagnostics.
This document does not apply to environmental samples.
Status: PublishedPublication date: 2022-04
Edition: 1Number of pages: 44
Technical Committee: ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems
- ICS :
- 11.100.01 Laboratory medicine in general
This standard contributes to the following Sustainable Development Goals:
Buy this standard
|std 1 166||PDF + ePub|
|std 2 166||Paper|
ISO/TS 5798:2022Stage: 60.60
Got a question?
Check out our FAQs
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)
Keep up to date with ISO
Sign up to our newsletter for the latest news, views and product information.